142 related articles for article (PubMed ID: 38226083)
1. Predictive Factors Associated With Survival in Periampullary Cancers Following Pancreaticoduodenectomy: A Retrospective Analysis.
Maharjan N; Bhandari RS; Lakhey PJ
Cureus; 2023 Dec; 15(12):e50607. PubMed ID: 38226083
[TBL] [Abstract][Full Text] [Related]
2. Predictors of survival in periampullary cancers following pancreaticoduodenectomy.
Hatzaras I; George N; Muscarella P; Melvin WS; Ellison EC; Bloomston M
Ann Surg Oncol; 2010 Apr; 17(4):991-7. PubMed ID: 20108122
[TBL] [Abstract][Full Text] [Related]
3. Results of pancreaticoduodenectomy in patients with periampullary adenocarcinoma: perineural growth more important prognostic factor than tumor localization.
van Roest MH; Gouw AS; Peeters PM; Porte RJ; Slooff MJ; Fidler V; de Jong KP
Ann Surg; 2008 Jul; 248(1):97-103. PubMed ID: 18580212
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for long-term survival after pancreaticoduodenectomy for periampullary adenocarcinoma. A retrospective cohort study.
Zakaria H; Sallam AN; Ayoub II; Gad EH; Taha M; Roshdy MR; Sweed D; Gaballa NK; Yassein T
Ann Med Surg (Lond); 2020 Sep; 57():321-327. PubMed ID: 32874564
[TBL] [Abstract][Full Text] [Related]
5. Predicting patient survival after pancreaticoduodenectomy for malignancy: histopathological criteria based on perineural infiltration and lymphovascular invasion.
Chen JW; Bhandari M; Astill DS; Wilson TG; Kow L; Brooke-Smith M; Toouli J; Padbury RT
HPB (Oxford); 2010 Mar; 12(2):101-8. PubMed ID: 20495653
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Outcomes and Prognostic Factors in Periampullary Carcinoma.
Sunil BJ; Seshadri RA; Gouthaman S; Ranganathan R
J Gastrointest Cancer; 2017 Mar; 48(1):13-19. PubMed ID: 27484980
[TBL] [Abstract][Full Text] [Related]
7. Histopathologic Analysis of Pancreaticoduodenectomy Specimen.
Dhakhwa R; Kafle N
JNMA J Nepal Med Assoc; 2016; 55(204):79-85. PubMed ID: 28029673
[TBL] [Abstract][Full Text] [Related]
8. Distribution and pathological features of pancreatic, ampullary, biliary and duodenal cancers resected with pancreaticoduodenectomy.
Chandrasegaram MD; Chiam SC; Chen JW; Khalid A; Mittinty ML; Neo EL; Tan CP; Dolan PM; Brooke-Smith ME; Kanhere H; Worthley CS
World J Surg Oncol; 2015 Feb; 13():85. PubMed ID: 25890023
[TBL] [Abstract][Full Text] [Related]
9. Is pancreatoduodenectomy justified for periampullary cancers with regional lymph node involvement?
Shyr YM; Su CH; Lo SS; Wang HC; Lui WY
Am Surg; 1995 Apr; 61(4):288-93. PubMed ID: 7893088
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Factors and the Role of Adjuvant Treatment in Periampullary Carcinoma: a Single-Centre Experience of 95 Patients.
Baghmar S; Agrawal N; Kumar G; Bihari C; Patidar Y; Kumar S; Chattopadhyay TK; Panda D; Arora A; Pamecha V
J Gastrointest Cancer; 2019 Sep; 50(3):361-369. PubMed ID: 29464529
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting survival in patients who underwent pancreaticoduodenectomy for periampullary cancers.
Şeren TD; Topgül K; Koca B; Erzurumlu K
Ulus Cerrahi Derg; 2015; 31(2):72-7. PubMed ID: 26170753
[TBL] [Abstract][Full Text] [Related]
12. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH
Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of carcinoembryonic antigen and carbohydrate antigen 19-9 in periampullary cancer patients receiving pancreaticoduodenectomy.
Park SH; Shin JH; Jung KU; Lee SR
Asian J Surg; 2021 Jun; 44(6):829-835. PubMed ID: 33478861
[TBL] [Abstract][Full Text] [Related]
14. Ampullary cancer of intestinal origin and duodenal cancer - A logical clinical and therapeutic subgroup in periampullary cancer.
Chandrasegaram MD; Gill AJ; Samra J; Price T; Chen J; Fawcett J; Merrett ND
World J Gastrointest Oncol; 2017 Oct; 9(10):407-415. PubMed ID: 29085567
[TBL] [Abstract][Full Text] [Related]
15. Association of Histopathologic Phenotype of Periampullary Adenocarcinomas With Survival.
Williams JL; Chan CK; Toste PA; Elliott IA; Vasquez CR; Sunjaya DB; Swanson EA; Koo J; Hines OJ; Reber HA; Dawson DW; Donahue TR
JAMA Surg; 2017 Jan; 152(1):82-88. PubMed ID: 27732711
[TBL] [Abstract][Full Text] [Related]
16. Perioperative Outcomes of Systematic Mesopancreas Dissection for Pancreatic and Periampullary Carcinoma at a Tertiary Referral Center From a Low Middle-Income Country.
Shrestha S; Dahal R; Maharjan N; Kandel B; Lakhey PJ
Cureus; 2023 Jul; 15(7):e42461. PubMed ID: 37637662
[TBL] [Abstract][Full Text] [Related]
17. Clinical Outcome of Ampullary Carcinoma: Single Cancer Center Experience.
Al-Jumayli M; Batool A; Middiniti A; Saeed A; Sun W; Al-Rajabi R; Baranda J; Kumer S; Schmitt T; Chidharla A; Kasi A
J Oncol; 2019; 2019():3293509. PubMed ID: 31186632
[TBL] [Abstract][Full Text] [Related]
18. Predictors of long-term survival after pancreaticoduodenectomy for peri-ampullary adenocarcinoma: A retrospective study of 5-year survivors.
El Nakeeb A; El Sorogy M; Ezzat H; Said R; El Dosoky M; Abd El Gawad M; Elsabagh AM; El Hanafy E
Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):443-449. PubMed ID: 30126828
[TBL] [Abstract][Full Text] [Related]
19. Longterm survival after pancreaticoduodenectomy for periampullary adenocarcinomas.
Chen SC; Shyr YM; Wang SE
HPB (Oxford); 2013 Dec; 15(12):951-7. PubMed ID: 23472708
[TBL] [Abstract][Full Text] [Related]
20. Lymph node ratio is an independent prognostic factor after resection of periampullary malignancies: data from a tertiary referral center in the middle East.
Shamseddine AI; Mukherji D; Melki C; Elias E; Eloubeidi M; Dimassi H; Khalife M; Abou-Alfa G; O'Reilly E; Faraj W
Am J Clin Oncol; 2014 Feb; 37(1):13-8. PubMed ID: 23111358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
